Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections

被引:74
作者
Ip, Margaret [1 ]
Rainer, Timothy H.
Lee, Nelson
Chan, Cangel
Chau, Shirley S. L.
Leung, Wingman
Leung, Man Fai
Tam, Tze Kin
Antonio, Gregory E.
Lui, Grace
Lau, Tze Kin
Hui, David S. C.
Fuchs, Dietmar
Renneberg, Reinhard
Chan, Paul K. S.
机构
[1] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Fac Med, Accid & Emer Acad Unit, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Fac Med, Dept Diagnost Radiol & Organ Imaging, Shatin, Hong Kong, Peoples R China
[5] Chinese Univ Hong Kong, Fac Med, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China
[6] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Peoples R China
[7] Innsbruck Med Univ, Div Biol Chem, Innsbruck, Austria
[8] Ludwig Boltzmann Inst AIDS Res, Innsbruck, Austria
关键词
procalcitonin; pneumonia; neopterin; C-reactive protein; CRP; lower respiratory tract infection (LRTI);
D O I
10.1016/j.diagmicrobio.2007.04.019
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The values of procalcitonin (PCT), neopterin, and C-reactive protein (CRP) alone and in combination to differentiate bacterial from viral etiology in patients with lower respiratory tract infections (LRTIs) were evaluated. Sera obtained on the day of hospitalization for LRTI from 139 patients with confirmed bacterial etiology and 128 patients with viral etiology were examined. A further 146 sera from healthy Chinese subjects with no infection were included as controls. The area under the receiver operating characteristic (ROC) curve (area under curve [AUC]) for distinguishing bacterial from viral infections was 0.838 for CRP and 0.770 for PCT (P < 0.05). The AUC for distinguishing viral from bacterial infections was 0.832 for neopterin (P < 0.05). When the markers were used in combination, AUC of ROC (CRP/neopterin) was 0.857, whereas (CRP x PCT)/neopterin was 0.856. Combination of 2 or all 3 of the biomarkers may improve the discriminatory power in delineating bacterial versus viral etiology in LRTI. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 14 条
[1]  
Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
[2]   Detection of serum neopterin for early assessment of dengue virus infection [J].
Chan, Cangel P. Y. ;
Choi, Junet W. Y. ;
Cao, Kai-Yuan ;
Wang, Ming ;
Gao, Yang ;
Zhou, Duan-Hua ;
Di, Biao ;
Xu, Hui-Fang ;
Leung, Man-Fai ;
Bergmann, Andreas ;
Lehmann, Matthias ;
Nie, Yong-Mei ;
Cautherley, George W. H. ;
Fuchs, Dietmar ;
Renneberg, Reinhard ;
Zheng, Bo-Jian .
JOURNAL OF INFECTION, 2006, 53 (03) :152-158
[3]   Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:: cluster-randomised, single-blinded intervention trial [J].
Christ-Crain, M ;
Jaccard-Stolz, D ;
Bingisser, R ;
Gencay, MM ;
Huber, PR ;
Tamm, M ;
Müller, B .
LANCET, 2004, 363 (9409) :600-607
[4]   Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia a Randomized trial [J].
Christ-Crain, Miriam ;
Stolz, Daiana ;
Bingisser, Roland ;
Muller, Christian ;
Miedinger, David ;
Huber, Peter R. ;
Zimmerli, Werner ;
Harbarth, Stephan ;
Tamm, Michael ;
Mueller, Beat .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (01) :84-93
[5]   Mixed community-acquired pneumonia in hospitalised patients [J].
de Roux, A ;
Ewig, S ;
García, E ;
Marcos, MA ;
Mensa, J ;
Lode, H ;
Torres, A .
EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (04) :795-800
[6]   Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization [J].
Lee, N. ;
Rainer, T. H. ;
Ip, M. ;
Zee, B. ;
Ng, M. H. ;
Antonio, G. E. ;
Chan, E. ;
Lui, G. ;
Cockram, C. S. ;
Sung, J. J. ;
Hui, D. S. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (12) :765-772
[7]   Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index [J].
Masiá, M ;
Gutiérrez, F ;
Shum, C ;
Padilla, S ;
Navarro, JC ;
Flores, E ;
Hernández, I .
CHEST, 2005, 128 (04) :2223-2229
[8]   Quality of care, process, and outcomes in elderly patients with pneumonia [J].
Meehan, TP ;
Fine, MJ ;
Krumholz, HM ;
Scinto, JD ;
Galusha, DH ;
Mockalis, JT ;
Weber, GF ;
Petrillo, MK ;
Houck, PM ;
Fine, JM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (23) :2080-2084
[9]   Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome [J].
Mitaka, C .
CLINICA CHIMICA ACTA, 2005, 351 (1-2) :17-29
[10]   Procalcitonin in children admitted to hospital with community acquired pneumonia [J].
Moulin, F ;
Raymond, J ;
Lorrot, M ;
Marc, E ;
Coste, J ;
Iniguez, JL ;
Kalifa, G ;
Bohuon, C ;
Gendrel, D .
ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 84 (04) :332-336